Company intelligence / Profile preview

Mantecorp Farmasa

Anápolis, Goiás, Brazil
Ownership
Private
Employees
~213
Development stage
Other
01

Overview

Mantecorp Farmasa develops and commercializes a wide range of prescription and over-the-counter drugs, dermocosmetics, vitamins, and biologicals; its efficacies and safety are proven in Brazil’s retail and hospital markets

Therapeutic areas
NeurologyEndocrinologyInfectious DiseasesGastroenterology
Modalities
Small moleculeBiologicvitamindermocosmetictherapeutic device
Industry
Biotech
02

Partnerships

Boehringer Ingelheim (raw material and plant)Sanofi (acquired product portfolio)

Beyond the preview

Go deeper on Mantecorp Farmasa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mantecorp Farmasa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call